The delta-8 market urgently needs more oversight and higher safety standards, according to a new viewpoint letter.
A new study has found that a single microdose of LSD can increase brain activity related to its reward system.
The largest study to date testing the ability of the psychedelic compound psilocybin to treat a psychiatric disorder has shown that the mushroom-derived drug, delivered in combination with integrative psychotherapy sessions, significantly reduced participants’ depression as compared to a placebo after three weeks.
If you need to quickly assess whether a patient might have cannabis use disorder, ask them how often they’ve used cannabis in the past year. At least, that is the suggestion put forward in new research published this week.
The certificate was awarded on October 20 to Viridis Laboratories, a cannabis lab in Michigan.
A new study published in the American Journal of Drug and Alcohol Abuse has found that rates of home cultivation are highest in states that permit recreational home cultivation, though the presence of physical cannabis retail stores showed some conflicting associations with home cultivation rates.
The state’s Office of Cannabis Management has removed the pass/fail limits associated with the total yeast and mold counts for cannabis flower and pre-rolls.
Recreational cannabis retailers in New York will have to be separated from the plant’s production under new guidance issued by state regulators.
Regulators in Colorado have found “potentially unsafe” levels of Aspergillus mold on batches of medical cannabis flower.